Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Etravirine (ETR) in Combination With Other Antiretrovirals (ARVs) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects

NCT01422330 is registered in ClinicalTrials.gov with Janssen R&D Ireland as lead sponsor.

NCT NCT01422330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01422330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Etravirine (ETR) in Combination With Other Antiretrovirals (ARVs) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects
Lead sponsor
Janssen R&D Ireland
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2011
Completion date
November 30, 2013
Enrollment
211 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv) infection